Adam Zaeske's most recent trade in Harmony Biosciences Holdings Inc was a trade of 7,500 Common Stock done . Disclosure was reported to the exchange on April 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harmony Biosciences Holdings Inc | Adam Zaeske | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2026 | 7,500 | 7,500 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Adam Zaeske | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2026 | 7,500 | 7,500 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Adam Zaeske | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.62 per share. | 07 Apr 2026 | 3,173 | 4,327 | - | 27.6 | 87,638 | Common Stock |
| Harmony Biosciences Holdings Inc | Adam Zaeske | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 56,900 | 56,900 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Adam Zaeske | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 16,200 | 16,200 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Adam Zaeske | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Adam Zaeske | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2025 | 30,000 | 30,000 | - | - | Restricted Stock Units |